350 related articles for article (PubMed ID: 19641357)
41. Development of nomogram to predict acute urinary retention or surgical intervention, with or without dutasteride therapy, in men with benign prostatic hyperplasia.
Slawin KM; Kattan MW; Roehrborn CG; Wilson T
Urology; 2006 Jan; 67(1):84-8. PubMed ID: 16413338
[TBL] [Abstract][Full Text] [Related]
42. Intravesical prostatic protrusion is better than prostate volume in predicting the outcome of trial without catheter in white men presenting with acute urinary retention: a prospective clinical study.
Mariappan P; Brown DJ; McNeill AS
J Urol; 2007 Aug; 178(2):573-7; discussion 577. PubMed ID: 17570437
[TBL] [Abstract][Full Text] [Related]
43. Incidence and factors predicting the detection of prostate cancer after transurethral resection of the prostate for clinically benign disease.
Bright EA; Manuel C; Goddard JC; Khan MA
Urol Int; 2009; 83(2):171-4. PubMed ID: 19752612
[TBL] [Abstract][Full Text] [Related]
44. Randomised, placebo controlled, double blind study of alfuzosin SR in patients undergoing trial without catheter following acute urinary retention.
Shah T; Palit V; Biyani S; Elmasry Y; Puri R; Flannigan GM
Eur Urol; 2002 Oct; 42(4):329-32; discussion 332. PubMed ID: 12361896
[TBL] [Abstract][Full Text] [Related]
45. Role of combined use of ketoconazole and tamsulosin in management of acute urinary retention due to benign prostatic obstruction (a randomized controlled trial).
Elbendary M; El-Gamal OM; Soliman MG; Tawfik A; Taha MR
Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):362-6. PubMed ID: 24018711
[TBL] [Abstract][Full Text] [Related]
46. Clinical and economic outcomes in patients treated for enlarged prostate.
Naslund MJ; Issa MM; Grogg AL; Eaddy MT; Black L
Am J Manag Care; 2006 Mar; 12(4 Suppl):S111-6. PubMed ID: 16551204
[TBL] [Abstract][Full Text] [Related]
47. Very high residual volumes should not prevent transurethral resection of the prostate being offered to men presenting with urinary retention.
Green W; Campain N; Peracha A; Ratan H; Walton T; Parkinson R
Scand J Urol; 2014 Dec; 48(6):549-53. PubMed ID: 25012873
[TBL] [Abstract][Full Text] [Related]
48. The effect of acute urinary retention on serum prostate-specific antigen level.
Aliasgari M; Soleimani M; Hosseini Moghaddam SM
Urol J; 2005; 2(2):89-92. PubMed ID: 17629877
[TBL] [Abstract][Full Text] [Related]
49. Acute urinary retention: medical management and the identification of risk factors for prevention.
Khastgir J; Khan A; Speakman M
Nat Clin Pract Urol; 2007 Aug; 4(8):422-31. PubMed ID: 17673913
[TBL] [Abstract][Full Text] [Related]
50. Prospective randomized placebo-controlled study to assess the safety and efficacy of silodosin in the management of acute urinary retention.
Kumar S; Tiwari DP; Ganesamoni R; Singh SK
Urology; 2013 Jul; 82(1):171-5. PubMed ID: 23561712
[TBL] [Abstract][Full Text] [Related]
51. The effect of urethral catheterisation on serum prostate- specific antigen levels in male patients with acute urinary retention.
Erdogan K; Gurdal M; Tekin A; Kirecci S; Sengor F
Yonsei Med J; 2003 Aug; 44(4):676-8. PubMed ID: 12950124
[TBL] [Abstract][Full Text] [Related]
52. Transurethral resection of the prostate (TURP)--in the treatment of benign prostatic hypertrophy (BPH) in Mekelle, Ethiopia.
Alemu MH
Ethiop Med J; 2009 Jan; 47(1):65-9. PubMed ID: 19743783
[TBL] [Abstract][Full Text] [Related]
53. Ultrasound prostate parameters as predictors of successful trial without catheter after acute urinary retention in patients ongoing medical treatment for benign prostatic hyperplasia: a prospective multicenter study.
DE Nunzio C; Voglino O; Cicione A; Tema G; Cindolo L; Bada M; Lombardo R; Nacchia A; Trucchi A; Ships L; Gacci M; Milanesi M; Cito G; Serni S; Tubaro A
Minerva Urol Nephrol; 2021 Oct; 73(5):625-630. PubMed ID: 33200904
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of the impact of a clinical pathway on the progression of acute urinary retention.
Gas J; Liaigre-Ramos A; Caubet-Kamar N; Beauval JB; Lesourd M; Prudhomme T; Huyghe E; Soulié M; Charpentier S; Gamé X
Neurourol Urodyn; 2019 Jan; 38(1):387-392. PubMed ID: 30418678
[TBL] [Abstract][Full Text] [Related]
55. Predictive factors for the success of trial without catheter for men with urinary retention.
Takanashi M; Ito H; Fukazawa T; Takizawa H; Hioki M; Shinoki R; Kawahara T; Kobayashi K
Low Urin Tract Symptoms; 2023 Sep; 15(5):173-179. PubMed ID: 37278133
[TBL] [Abstract][Full Text] [Related]
56. Benign prostatic hyperplasia presenting with renal failure--what is the role for transurethral resection of the prostate (TURP)?
Thomas AZ; Thomas AA; Conlon P; Hickey D; Little DM
Ir Med J; 2009 Feb; 102(2):43-4. PubMed ID: 19405316
[TBL] [Abstract][Full Text] [Related]
57. Incidence of primary and recurrent acute urinary retention between 1998 and 2003 in England.
Cathcart P; van der Meulen J; Armitage J; Emberton M
J Urol; 2006 Jul; 176(1):200-4; discussion 204. PubMed ID: 16753401
[TBL] [Abstract][Full Text] [Related]
58. Peak flow rate is the best predictor of acute urinary retention following prostate brachytherapy: our experience and literature review.
Ikeda T; Shinohara K
Int J Urol; 2009 Jun; 16(6):558-60. PubMed ID: 19456987
[TBL] [Abstract][Full Text] [Related]
59. Transurethral microwave thermotherapy of the prostate--evaluation with MRI and analysis of parameters relevant to outcome.
Vesely S; Müller M; Knutson T; Peeker R; Hellström M; Dahlstrand C
Scand J Urol Nephrol; 2008; 42(1):53-8. PubMed ID: 18210336
[TBL] [Abstract][Full Text] [Related]
60. Alfuzosin once daily facilitates return to voiding in patients in acute urinary retention.
McNeill SA; Hargreave TB;
J Urol; 2004 Jun; 171(6 Pt 1):2316-20. PubMed ID: 15126812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
